β¨ Medicines Distribution Consent
NEW ZEALAND GAZETTE, No. 146
28 OCTOBER 2010
Product: Zarator
Active Ingredient: Atorvastatin calcium 10.85mg equivalent to 10mg atorvastatin
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Pfizer Pharmaceuticals LLC, Vega Baja, Puerto Rico
Godecke GmbH, Freiburg, Germany
Pfizer Ireland Pharmaceuticals, County Cork, Ireland
Farmea, Angers, France
Product: Zarator
Active Ingredient: Atorvastatin calcium 21.7mg equivalent to 20mg atorvastatin
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Pfizer Pharmaceuticals LLC, Vega Baja, Puerto Rico
Godecke GmbH, Freiburg, Germany
Pfizer Ireland Pharmaceuticals, County Cork, Ireland
Farmea, Angers, France
Product: Zarator
Active Ingredient: Atorvastatin calcium 86.8mg equivalent to 80mg atorvastatin
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Pfizer Pharmaceuticals LLC, Vega Baja, Puerto Rico
Godecke GmbH, Freiburg, Germany
Pfizer Ireland Pharmaceuticals, County Cork, Ireland
Farmea, Angers, France
Product: Zarator
Active Ingredient: Atorvastatin calcium 43.4mg equivalent to 40mg atorvastatin
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Pfizer Pharmaceuticals LLC, Vega Baja, Puerto Rico
Godecke GmbH, Freiburg, Germany
Pfizer Ireland Pharmaceuticals, County Cork, Ireland
Farmea, Angers, France
Dated this 22nd day of October 2010.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8368
Provisional Consent to the Distribution of New Medicines
Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Mitomycin for Injection
Active Ingredient: Mitomycin 5mg
Dosage Form: Powder for injection
New Zealand Sponsor: Accord Healthcare NZ Limited
Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India
Note: This consent is valid for two years from the date of publication of this notice.
Product: Mitomycin for Injection
Active Ingredient: Mitomycin 20mg
Dosage Form: Powder for injection
New Zealand Sponsor: Accord Healthcare NZ Limited
Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 22nd day of October 2010.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8369
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare22 October 2010
Medicines, Distribution, Consent, Zarator, Atorvastatin
- JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health
π₯ Provisional Consent to the Distribution of New Medicines
π₯ Health & Social Welfare22 October 2010
Medicines, Provisional Consent, Mitomycin, Injection
- JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health
NZ Gazette 2010, No 146